Background

DoMore Diagnostics is a pioneer in utilizing artificial intelligence to increase the prognostic and predictive value of cancer tissue biopsies. The company is based on extensive research at top universities with deep learning in histology image analysis. These new methods have resulted in fully automated histotyping that provide objective and precise prognostic information about patient outcomes. This novel histotyping can guide selection of therapy to avoid over- and undertreatment. It can also make cancer drug development more effective by ensuring more precise diagnosis and prognosis, which is the fundament for precision medicine.